Seeking Alpha

slusagar

slusagar
Send Message
View as an RSS Feed
View slusagar's Comments BY TICKER:
Latest  |  Highest rated
  • CombiMatrix: A Turnaround Story For 2014 [View article]
    I'm posting an important piece I just read online on yahoo (see below). In fact, I've also heard similar things through the grapevine, and have no doubt on its validity!

    At the last conference call, the team briefly alluded to upcoming exciting new products to be released later this year was discussed. Details on the new products will follow formal announcement (target month is actually October), but as an investor I'm pleased to announce that these products will involve the field of REI (reproductive endocrinology and infertility). If you have never heard of this field of medicine or have little experience or understanding, do so research. But as an investor highly knowledgeable about this field, trust me you should be thrilled b/c REI is a RAPIDLY growing field in high demand (getting an open/available REI appointment as a patient often takes weeks!). Additionally, b/c a lot of REI is not covered by insurance, most involved patients PAY CASH (and can afford it). That means the tests Combimatrix will be offering the REI doc's will be reimbursed, almost fully, without insurance battles/struggles. This is HUGE for Combimatrix ($$$).

    At today's price, you'd be crazy not to load up on shares. The bottom is definitely here, with upward trajectory almost certain.
    Sep 13, 2014. 02:19 AM | 1 Like Like |Link to Comment
  • CombiMatrix Turns In Another Record Quarter, Stock Remains Undervalued [View article]
    should be one in CBMX yahoo message board somewhere recently.

    not worried about lawsuit, should be resolved soon enough (CMBX team is not worried). incoming cash and continued growth will attractive knowledgeable investors. shocked that price has stayed this low still, guess it's an early X-mas gift for folks.
    Sep 12, 2014. 03:58 PM | Likes Like |Link to Comment
  • CombiMatrix Turns In Another Record Quarter, Stock Remains Undervalued [View article]
    I'm posting an important piece I just read online on yahoo (see below). In fact, I've also heard similar things through the grapevine, and have no doubt on its validity!!

    At the last conference call, the team briefly alluded to upcoming exciting new products to be released later this year was discussed. Details on the new products will follow formal announcement (target month is actually October), but as an investor I'm pleased to announce that these products will involve the field of REI (reproductive endocrinology and infertility). If you have never heard of this field of medicine or have little experience or understanding, do so research. But as an investor highly knowledgeable about this field, trust me you should be thrilled b/c REI is a RAPIDLY growing field in high demand (getting an open/available REI appointment as a patient often takes weeks!). Additionally, b/c a lot of REI is not covered by insurance, most involved patients PAY CASH (and can afford it). That means the tests Combimatrix will be offering the REI doc's will be reimbursed, almost fully, without insurance battles/struggles. This is HUGE for Combimatrix ($$$).

    At today's price, you'd be crazy not to load up on shares. The bottom is definitely here, with upward trajectory almost certain.
    Sep 12, 2014. 03:29 PM | Likes Like |Link to Comment
  • Discount After Earnings Creates An Attractive Entry For Combimatrix [View article]
    Sure CBMX (like all biotech) has taken a hit recently, but expect a long-overdue PR this or next week. Recent CMO and cytogenetic director (both MDs) upgrades are HUGE for the company. Names alone are going to bring in clients (one was a powerhouse at Quest). Shares are frankly a steal right now (I've doubled up). This should pop well before the mid-May earnings report.
    Apr 16, 2014. 03:55 PM | 1 Like Like |Link to Comment
  • Rocket Fuel's Fall From Grace May Be Temporary [View article]
    I know FUEL has taken a beating as of late, but insiders tell me the # are still solid and frankly growing like mad. This is going to rebound well before May 15 powerhouse earnings. Agreed, total steal at this price. I certainly doubled down.
    Apr 16, 2014. 03:45 PM | Likes Like |Link to Comment
  • Rocket Fuel's Fall From Grace May Be Temporary [View article]
    With Rubicon IPO'ing tomorrow (RUBI), expect more attention paid to dig advertising powerhouses like FUEL -- FUEL is insanely cheap right now at this price. Check the 6-month history parabolic price chart: a swing back up is coming up (and when it does, it goes up quickly). I've loaded up.
    Apr 1, 2014. 04:28 PM | Likes Like |Link to Comment
  • CombiMatrix: A Turnaround Story For 2014 [View article]
    CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
    Demand Grows for Chromosomal Microarray Testing for Miscarriage Analysis


    IRVINE, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that it has been selected by American Pathology Partners (AP2) to provide its chromosomal microarray analysis (CMA) testing for miscarriage analysis to AP2 patients. American Pathology Partners is creating a nationwide network of leading anatomic pathology laboratories.


    ----------------------...
    I'm in the industry, so if you haven't kept up, this yet ANOTHER new contract for CBMX and a biggie at that. Speaks volumes (literally). Check the history: almost every time they sign out a new client CBMX pops (and then shorts kill it back down). This time around, more of a gradual rise without a decline. The insane volality of this stock is gone. This is a serious quality play, both long term and short term, latter in particular b/c a buyout can happen ANY day now (SQNM, ILMN already in talks). I loaded up and am sitting tight until payday
    Mar 14, 2014. 03:58 PM | 1 Like Like |Link to Comment
  • Discount After Earnings Creates An Attractive Entry For Combimatrix [View article]
    CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
    Demand Grows for Chromosomal Microarray Testing for Miscarriage Analysis

    IRVINE, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, today announced that it has been selected by American Pathology Partners (AP2) to provide its chromosomal microarray analysis (CMA) testing for miscarriage analysis to AP2 patients. American Pathology Partners is creating a nationwide network of leading anatomic pathology laboratories.

    ----------------------...
    I'm in the industry, so if you haven't kept up, this yet ANOTHER new contract for CBMX and a biggie at that. Speaks volumes (literally). Check the history: almost every time they sign out a new client CBMX pops (and then shorts kill it back down). This time around, more of a gradual rise without a decline. The insane volality of this stock is gone. This is a serious quality play, both long term and short term, latter in particular b/c a buyout can happen ANY day now (SQNM, ILMN already in talks). I loaded up and am sitting tight until payday
    Mar 14, 2014. 03:57 PM | 2 Likes Like |Link to Comment
  • Discount After Earnings Creates An Attractive Entry For Combimatrix [View article]
    Here now in Dana Point CA (ROTH conference) and everyone here is talking nonstop about CBMX. I see several big VC players (former colleagues) as well, licking their chops on the soon-to-be 5+ price. Rumors abound on SQNM/others in buyout talks.
    Mar 12, 2014. 05:47 PM | 1 Like Like |Link to Comment
  • Discount After Earnings Creates An Attractive Entry For Combimatrix [View article]
    Great article. Can't emphasize enough how having a young and energetic CEO now (with strong biotech background/experience) has really changed the entire landscape of the company. Sure it's still having some "pop and drops", but the days of crazy intraday volatility are gone. Stability and growth are already on the horizon. As you noted, major institutions and also many VC folks are loading up on this. Expect an AFFX-like rebound, and soon. Current price is a steal (loaded up bigtime myself).

    Major talks of SQNM buyout are definitely real (as an aside, a company called Ascend actually offered $10/share for CBMX a while ago -- CBMX turned it down, expecting more value than this). ILMN has also put inquiries into buying out CBMX.
    Feb 25, 2014. 01:39 PM | 3 Likes Like |Link to Comment
  • Cramer's Lightning Round - Valero Is The Nation's Best Refiner (12/17/13) [View article]
    VEEV is rocket back, very soon. it's a solid flip and great long also
    Dec 18, 2013. 12:10 PM | Likes Like |Link to Comment
  • The Ad-Tech Sector Is Beginning To Resemble 3-D At Its Early Stage Of Excitement [View article]
    ps, I'm at BMO tech conference in NY...all everyone is talking about is FUEL. Wouldn't be shocked to see a major pop in next few days at upcoming PR
    Dec 11, 2013. 11:27 AM | Likes Like |Link to Comment
  • The Ad-Tech Sector Is Beginning To Resemble 3-D At Its Early Stage Of Excitement [View article]
    hands down FUEL is the leader of the pack. Expect a strong and quick return to 60 very very soon.
    Dec 10, 2013. 07:58 PM | 1 Like Like |Link to Comment
  • Rocket Fuel's Q3 Earnings Show Sky-High Growth - Here's Why The Growth Will Continue [View article]
    w-t-f is going on? why the week-long drop?
    Nov 21, 2013. 12:49 PM | Likes Like |Link to Comment
  • Best Buy: Monthly Retail Sales Data Bode Well For Best Buy [View article]
    with a drop like today, no brainer for great buying opportunity. hope folks loaded up for quick flip $.
    Nov 19, 2013. 11:25 PM | 1 Like Like |Link to Comment
COMMENTS STATS
25 Comments
12 Likes